Literature DB >> 27221893

Incidence and Mortality of Liver Cancer and Their Relationship with Development in Asia.

Maryam Mohammadian1, Ali Soroush, Abdollah Mohammadian-Hafshejani, Farhad Towhidi, Fatemeh Hadadian, Hamid Salehiniya.   

Abstract

BACKGROUND: Liver cancer (LC) is the sixth world most common cancer and the second leading cause of cancer death. Due to the importance and necessity of awareness about the incidence and mortality of diseases to perform prevention programs, this study focused on data for LC and its relationship with the human development index (HDI) and its components in Asia in 2012.
MATERIALS AND METHODS: This ecological study was based on GLOBOCAN data for Asian countries. We assessed correlations between standardized incidence rates (SIR) and standardized mortality rates (SMR) of LC with HDI and its components using of SPSS18.
RESULTS: A total of 582,420 incident cases and 557,097 deaths were recorded in Asian countries in 2012. The five with the highest SIR were Mongolia, Lao PDR, Vietnam, Republic of Korea and Thailand and those with the highest SMR were Mongolia, Lao PDR, Vietnam, Cambodia and Thailand. A negative relation was observed between HDI and LC for SIR of 0.049 (P=0.748) and for SMR of 0.07 (P=0.645), with life expectancy at birth a positive relation for SIR of 0.061 (P=0.687) and a negative relation for SMR of 0.079 (P=0.603), with the average years of education a negative relation fo SIR of 0.476 (p=0.952) and for SMR of 0.032 (P=0.832), and with the country income level per person a negative relation for SMI of 0.11 (p=0.465) and for SMR of 0.113 (P=0.455).
CONCLUSIONS: The incidence of LC is more in less developed and developing countries but statistically significant correlations were not found between standardized incidence and mortality rates of LC, and HDI and its dimensions.

Entities:  

Mesh:

Year:  2016        PMID: 27221893     DOI: 10.7314/apjcp.2016.17.4.2041

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis.

Authors:  Soheil Hassanipour; Majid Mohammadzadeh; Fariborz Mansour-Ghanaei; Mohammad Fathalipour; Farahnaz Joukar; Hamid Salehiniya; Elham Abdzadeh; Ali Akbar Samadani; Hossein-Ali Nikbakht; Morteza Arab-Zozani
Journal:  J Gastrointest Cancer       Date:  2019-06

2.  Modeling the Trend Changes of Liver Cancer Mortality in the 6 WHO Regions.

Authors:  Seyedeh Fatemeh Musavi Ezmareh; Kamran Mehrabani; Hadi Raeisi Shahraki
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

Review 3.  Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.

Authors:  Nighat Gull; Fareeha Arshad; Gowhar A Naikoo; Israr Ul Hassan; Mona Zamani Pedram; Arif Ahmad; Alaa A A Aljabali; Vijay Mishra; Saurabh Satija; Nitin Charbe; Poonam Negi; Rohit Goyal; Ángel Serrano-Aroca; Mazhar S Al Zoubi; Mohamed El-Tanani; Murtaza M Tambuwala
Journal:  J Gastrointest Cancer       Date:  2022-03-14

4.  Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012.

Authors:  Maryam Mohammadian; Reza Pakzad; Farhad Towhidi; Behnam Reza Makhsosi; Abbas Ahmadi; Hamid Salehiniya
Journal:  Clujul Med       Date:  2017-07-15

5.  ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE.

Authors:  Haoxuan Luo; Yan Chen; Baoguo Sun; Ting Xiang; Shijun Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

Review 6.  A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.

Authors:  Bagher Farhood; Behzad Raei; Reza Malekzadeh; Maryam Shirvani; Masoud Najafi; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05

7.  Disease frequency among inpatients at a tertiary general hospital in Lao PDR.

Authors:  Viengsakhone Louangpradith; Bounfeng Phoummalaysith; Tetsuyoshi Kariya; Yu Mon Saw; Eiko Yamamoto; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2020-02       Impact factor: 1.131

Review 8.  The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.

Authors:  Soheil Hassanipour; Mouhebat Vali; Saber Gaffari-Fam; Hossein-Ali Nikbakht; Elham Abdzadeh; Farahnaz Joukar; Akram Pourshams; Afshin Shafaghi; Mahdi Malakoutikhah; Morteza Arab-Zozani; Hamid Salehiniya; Fariborz Mansour-Ghanaei
Journal:  EXCLI J       Date:  2020-01-13       Impact factor: 4.068

9.  Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.

Authors:  Piyush Nathani; Purva Gopal; Nicole Rich; Adam Yopp; Takeshi Yokoo; Binu John; Jorge Marrero; Neehar Parikh; Amit G Singal
Journal:  Gut       Date:  2020-05-12       Impact factor: 23.059

Review 10.  Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid.

Authors:  Claudia Ceci; Pedro M Lacal; Lucio Tentori; Maria Gabriella De Martino; Roberto Miano; Grazia Graziani
Journal:  Nutrients       Date:  2018-11-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.